 Intravenous immunoglobulin therapy prevention infection high-risk premature infants report multicenter double-blind study effectiveness immunoglobulin Ig therapy prophylaxis infection high-risk preterm infants thirty-five premature newborns double-blind trial treatment placebo groups Thirty-five infants Ig group placebo group episodes certain infection Thirty infants Ig group placebo group episodes probable infection significant differences incidence certain probable infection treated control infants Nevertheless infants certain probable episodes infection Ig group placebo group possible deleterious effect administration large amounts polyspecific Ig